Form 4: Processa Pharmaceuticals Director Acquires Shares

Khoso Baluch, a Director at Processa Pharmaceuticals, Inc., acquired 203 shares of common stock through a time-based service award.

Summary

• Khoso Baluch, a Director at Processa Pharmaceuticals, Inc. (PCSA), acquired 203 shares of common stock on June 26, 2026.
• This acquisition was part of a time-based service award.
• Following this transaction, Baluch beneficially owns 2,528 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider transaction related to compensation rather than a significant strategic or financial event.

Positives

• Director Khoso Baluch received a time-based service award, indicating a form of employee/director compensation.
• The acquisition of 203 shares increases the director's direct beneficial ownership.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into ownership changes by company directors and officers. This specific filing indicates a routine compensation event for a director at Processa Pharmaceuticals.

Stakeholder Impact

• Shareholders: Increased transparency regarding director's beneficial ownership.

Key Dates

Keywords

Processa Pharmaceuticals, PCSA, Form 4, SEC Filing, Director, Stock Acquisition, Beneficial Ownership, Service Award